CSF2 and melanoma: Immunocompetent (C57BL/6J)GM-CSF incorporation resulted in increased DC recruitment. Addition of CpG-ODN and B16F10 lysates into scaffold vaccine design induced 90% survival in a prophylactic B16F10 melanoma model